proline-nitric oxide

Known as: C5H7N3O4Na2.CH3OH, PROLI-NO 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
0119962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Previous studies have indicated that lysine (K)‑specific demethylase 3A (KDM3A) is associated with diverse diabetes‑associated… (More)
Is this relevant?
2017
2017
PURPOSE To analyze the effect of liver steatosis and obesity on pharmacokinetic profile of two structurally-related liver… (More)
Is this relevant?
2011
2011
Arsenic is a cancer chemotherapeutic but hepatotoxicity can be a limiting side effect. O(2)-vinyl 1-[2-(carboxylato)pyrrolidin-1… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
V-PYRRO/NO is a well studied nitric oxide (NO) prodrug which has been shown to protect human liver cells from arsenic… (More)
Is this relevant?
2009
2009
Inorganic arsenic shows great promise in human cancer chemotherapy, although hepatotoxicity is a major limiting side-effect. O(2… (More)
Is this relevant?
2007
2007
The sensitivity to decomposition of the nitric oxide (NO) donor ion, 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate… (More)
Is this relevant?
1996
1996
Reaction of nitric oxide (NO) with L-proline in methanolic sodium methoxide yields a diazeniumdiolate product, C5H7N3O4Na2.CH3OH… (More)
Is this relevant?